Consolidated Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7603820

Concept As at
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,481,772,000 JPY
-1,717,214,000 JPY
Depreciation
35,123,000 JPY
66,688,000 JPY
Impairment losses
5,701,000 JPY
9,629,000 JPY
Interest and dividend income
-27,000 JPY
-35,000 JPY
Increase (decrease) in provision for retirement benefits
-399,000 JPY
-11,249,000 JPY
Loss (gain) on sale of property, plant and equipment
-13,000 JPY
JPY
Subtotal
-1,509,410,000 JPY
-1,767,150,000 JPY
Decrease (increase) in trade receivables
-16,302,000 JPY
376,000 JPY
Income taxes paid
-2,420,000 JPY
-2,732,000 JPY
Increase (decrease) in trade payables
1,444,000 JPY
-346,000 JPY
Net cash provided by (used in) operating activities
-1,512,022,000 JPY
-1,769,848,000 JPY
Other, net
-47,618,000 JPY
-82,980,000 JPY
Interest and dividends received
28,000 JPY
35,000 JPY
Interest paid
-221,000 JPY
JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-17,646,000 JPY
-34,920,000 JPY
Proceeds from sale of property, plant and equipment
80,000 JPY
JPY
Net cash provided by (used in) investing activities
-17,566,000 JPY
-36,211,000 JPY
Cash flows from financing activities
Proceeds from issuance of bonds
300,000,000 JPY
JPY
Redemption of bonds
-212,500,000 JPY
JPY
Net cash provided by (used in) financing activities
569,226,000 JPY
2,053,090,000 JPY
Net increase (decrease) in cash and cash equivalents
-960,361,000 JPY
247,031,000 JPY
Cash and cash equivalents
2,305,026,000 JPY
3,265,388,000 JPY
3,018,356,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.